曠世控股(01925.HK)進一步認購基金
格隆匯11月16日丨曠世控股(01925.HK)發佈公吿,公司的間接全資附屬公司寧波曠世於2022年11月15日認購第三隻基金(即竹潤樂在81號私募證券投資基金)的權益,金額為人民幣1000萬元,該認購由集團的盈餘現金儲備提供資金。
該基金經理上海竹潤投資有限公司於2015年根據中國法律成立,並於2019年10月在中國證券投資基金業協會登記為私募基金經理(登記編號:P1070287),主要在中國從事資產管理服務。上海竹潤投資有限公司分別由樂徵楠先生及慄葉先生最終擁有60%及40%權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.